Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K-Fast Holding B | KFASTB | Apr 19, 2024 | 18.60 | +0.43 |
K2A Knaust & Andersson Fastigheter B | K2AB | Apr 19, 2024 | 9.98 | +2.89 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Apr 19, 2024 | 205.00 | +0.49 |
KABE Group B | KABEB | Apr 19, 2024 | 332.00 | -0.60 |
Kakel Max | KAKEL | Apr 19, 2024 | 9.00 | -2.17 |
Kallebäck Property Invest | KAPIAB | Apr 19, 2024 | 182.00 | -0.55 |
Kambi Group | KAMBI | Apr 19, 2024 | 86.95 | -1.64 |
Kancera | KAN | Apr 19, 2024 | 1.49 | -0.67 |
Karnell Group AB (publ) | KARNELB | 0.00 | 0.00 | |
Karnov Group | KAR | Apr 19, 2024 | 63.90 | -0.31 |
Karolinska Development B | KDEV | Apr 19, 2024 | 1.52 | -0.13 |
Katalysen Ventures AB | KAV | Apr 19, 2024 | 18.00 | 0.00 |
KebNi B | KEBNIB | Apr 19, 2024 | 1.51 | -1.56 |
Kentima Holding B | KENH | Apr 19, 2024 | 1.79 | -6.28 |
Kiliaro | KILI | Apr 19, 2024 | 1.05 | +2.94 |
Kindred Group SDB | KINDSDB | Apr 19, 2024 | 123.70 | -0.08 |
Kinnevik A | KINVA | Apr 19, 2024 | 112.80 | -0.35 |
Kinnevik B | KINVB | Apr 19, 2024 | 112.50 | +0.09 |
Kjell Group | KJELL | Apr 19, 2024 | 19.00 | 0.00 |
KlaraBo | KLARAB | Apr 19, 2024 | 18.90 | -1.05 |
Klaria Pharma Holding | KLAR | Apr 19, 2024 | 0.25 | +2.94 |
Klimator | KLIMAT | Apr 19, 2024 | 1.48 | +0.68 |
Knowit | KNOW | Apr 19, 2024 | 148.20 | -0.54 |
Kollect on Demand Holding | KOLL | Apr 19, 2024 | 0.69 | -6.23 |
Kontigo Care | KONT | Apr 19, 2024 | 2.35 | +2.17 |
Kopparbergs B | KOBRB | Apr 19, 2024 | 117.00 | -0.43 |
Kopy Goldfields | KOPY | Apr 19, 2024 | 0.30 | 0.00 |
Krona Public Real Estate | KRONA | Apr 19, 2024 | 37.80 | -6.44 |
Kvix | KVIX | Apr 19, 2024 | 0.24 | -11.11 |
Lagercrantz Group B | LAGRB | Apr 19, 2024 | 159.20 | -0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.